Efficacy of LGE ‐MRI‐Guided Fibrosis Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation: The DECAAF II Trial: Study Design

ConclusionThe DECAAF II trial is the first prospective, randomized, multicenter trial of patients with persistent AF using imaging defined atrial fibrosis as a treatment target. The trial will help define an optimal approach to catheter ablation of persistent AF, further our understanding of influencers of ablation lesion formation, and refine selection criteria for ablation based on atrial myopathy burden.This article is protected by copyright. All rights reserved.

Source: Journal of Cardiovascular Electrophysiology - February 18, 2021 Category: Cardiology Authors: Nassir F. Marrouche, Tom Greene, J Michael Dean, Eugene G. Kholmovski, Leonie Morrison ‐de Boer, Moussa Mansour, Hugh Calkins, Francis Marchlinski, David Wilber, Gerhard Hindricks, Christian Mahnkopf, Pierre Jais, Prashanthan Sanders, Johan Tags: ORIGINAL ‐ ELECTROPHYSIOLOGY Source Type: research